A clinical stage biopharmaceutical company focused on rare respiratory diseases.

Sectors
Healthcare
Life Sciences
First Invested
2021
Public/PIPES
Company Status
IPO/Public
NASDAQ: SVRA
Associated Team
Blake Wu
Paul Walker
Website
Savara